OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q1 2019. The put-call ratio across all filers is 0.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $179,187 | -63.5% | 57,066 | -40.0% | 0.00% | – |
| Q2 2023 | $490,737 | +39.4% | 95,104 | +42.4% | 0.00% | – |
| Q1 2023 | $351,936 | +27.8% | 66,781 | -31.9% | 0.00% | – |
| Q4 2022 | $275,408 | +14.8% | 98,010 | +68.9% | 0.00% | – |
| Q3 2022 | $240,000 | +51.9% | 58,035 | +47.6% | 0.00% | – |
| Q2 2022 | $158,000 | -35.8% | 39,311 | -20.7% | 0.00% | – |
| Q1 2022 | $246,000 | -57.5% | 49,571 | -40.4% | 0.00% | – |
| Q4 2021 | $579,000 | +10.1% | 83,107 | +57.9% | 0.00% | – |
| Q3 2021 | $526,000 | +2.9% | 52,644 | +46.1% | 0.00% | – |
| Q2 2021 | $511,000 | -41.0% | 36,038 | -31.7% | 0.00% | – |
| Q1 2021 | $866,000 | -29.8% | 52,789 | -11.4% | 0.00% | – |
| Q4 2020 | $1,233,000 | +25.9% | 59,573 | -53.7% | 0.00% | – |
| Q3 2020 | $979,000 | +37.5% | 128,738 | +50.4% | 0.00% | – |
| Q2 2020 | $712,000 | +947.1% | 85,579 | +516.3% | 0.00% | – |
| Q1 2020 | $68,000 | -5.6% | 13,887 | -23.1% | 0.00% | – |
| Q4 2019 | $72,000 | +35.8% | 18,057 | +1.3% | 0.00% | – |
| Q3 2019 | $53,000 | +3.9% | 17,818 | +50.3% | 0.00% | – |
| Q2 2019 | $51,000 | +13.3% | 11,854 | +3.8% | 0.00% | – |
| Q1 2019 | $45,000 | -57.1% | 11,419 | -56.5% | 0.00% | – |
| Q4 2018 | $105,000 | +72.1% | 26,271 | +197.0% | 0.00% | – |
| Q3 2018 | $61,000 | +45.2% | 8,846 | +42.0% | 0.00% | – |
| Q2 2018 | $42,000 | +200.0% | 6,231 | +175.8% | 0.00% | – |
| Q1 2018 | $14,000 | +16.7% | 2,259 | -15.6% | 0.00% | – |
| Q4 2017 | $12,000 | +71.4% | 2,678 | +133.9% | 0.00% | – |
| Q3 2017 | $7,000 | -86.3% | 1,145 | -79.3% | 0.00% | – |
| Q2 2017 | $51,000 | -29.2% | 5,527 | -29.0% | 0.00% | – |
| Q1 2017 | $72,000 | +7.5% | 7,782 | -2.8% | 0.00% | – |
| Q4 2016 | $67,000 | +81.1% | 8,009 | +49.2% | 0.00% | – |
| Q3 2016 | $37,000 | +85.0% | 5,369 | +36.8% | 0.00% | – |
| Q2 2016 | $20,000 | +66.7% | 3,926 | +227.2% | 0.00% | – |
| Q1 2016 | $12,000 | -70.7% | 1,200 | -72.3% | 0.00% | – |
| Q4 2015 | $41,000 | +583.3% | 4,333 | +967.2% | 0.00% | – |
| Q3 2015 | $6,000 | -82.9% | 406 | -75.5% | 0.00% | – |
| Q2 2015 | $35,000 | +3400.0% | 1,660 | +7117.4% | 0.00% | – |
| Q1 2015 | $1,000 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |